What do patients really want to know about recovery? Read more about the idea, our collaboration with Aalto University students, and the next steps: www.ficebo.com/post/how-can... Photo source: Aalto University
Tero Järvinen
@terojarvinen.bsky.social
Professor & Chief Surgeon Tero Järvinen, M.D., Ph.D. Orthopedic sports medicine surgeon who got into molecular cell biology of tissue regeneration
NO evidence this kinda DATA DATA DATA tech helps health outcomes. Wellness & longevity marketing push idea that more data is always better and empowering. Not true. How Oura’s rings found their way onto millions of fingers www.economist.com/business/202...
How Oura’s rings found their way onto millions of fingers
Its business is booming as consumers look to take charge of their health
economist.com
Meet Leo, research intern at FICEBO! This summer, upper secondary school student Leo worked on developing an online course on evidence-based medicine. #FICEBO #EvidenceBasedMedicine #ResearchInternship
The latest issue of Molecular Therapy Advances features original research focused on a dual-AAV otoferlin gene therapy for congenital deafness, anti-CAR antibodies in patients treated with anti-BCMA CAR T cell therapy, and more. https://bit.ly/4cWWPVl
How do human large blood vessels respond to hypoxia? Paucity of evidence until large arteries & veins collected after severe lower extremity trauma reveal rapid, but transient intimal hyperplasia and adventitial angiogenesis from veins. @evborg.bsky.social @navbo.bsky.social rdcu.be/XyAQYUmiqQma
We are in Halo! Our drug screening technology for homing and tissue penetrating macrocyclic peptides based on in vivo phage display & microdialysis (www.life-science-alliance.org/content/8/5/...) & macrocyclic homing peptides for targeted drug delivery are presented. www.halo.science/profile/tero...
Tero Järvinen's profile
Tero Järvinen is a Principal Investigator at Tampere University. Expertise in Biopharmaceutics, Cardiovascular, Molecular Biology. Explore collaboration opportunities on Halo Science.
halo.science
Great tribute to the discovery by Barbara Pearce of clathrin, the first protein found to act in membrane traffic, along with her mentoring and support of the pioneers (many of whom were other women) who revealed the workings of this key player in cellular function.
Traffic@traffic-journal.bsky.social · last mo.Happy 50th anniversary, Clathrin! onlinelibrary.wiley.com/doi/full/10.... @effc.bsky.social
FICEBO’s Thomas Ibounig co-authored a new JAMA Internal Medicine review with researchers Romi Haas and Rachelle Buchbinder from Monash University. Read more about the study and Thomas’s upcoming dissertation on our website: www.ficebo.com/post/new-rev...
"Fragile skin may benefit from decoration" commentary on @nystromlab.bsky.social publication on the potential of decorin-based therapeutics for the treatment of RDEB. @matrixbiologie.bsky.social @epidermophyte.bsky.social @charitydebra.bsky.social Take a look www.sciencedirect.com/science/arti...
Fragile skin may benefit from decoration
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
sciencedirect.com
Together w. Dr. Y. Liao we wrote a commentary on @nystromlab.bsky.social publication on the potential of decorin-based therapeutics for the treatment of RDEB. Take a look at "Fragile skin may benefit from decoration" @matrixbiologie.bsky.social www.sciencedirect.com/science/arti...
Fragile skin may benefit from decoration: Molecular Therapy Advances www.cell.com/molecular-th...
Fragile skin may benefit from decoration
Recessive dystrophic epidermolysis bullosa (RDEB) is a severe hereditary blistering disorder characterized by fragility of the skin and mucous membranes due to mutations in the COL7A1 gene, which enco...
cell.com
Honestly, the way the entire pub chants "wanker" any time Infantino appears on screen is truly heartwarming.
Hot off the press! We demonstrate in Cancer Res that the αv integrin- and neuropilin-1 (NRP-1)-dual targeting iRGD peptide (in phase II clinical trials) reverses some of these tumor microenvironment features by inhibiting TGF-β activation in the tumor: aacrjournals.org/cancerres/ar...
Glad to see @jci.org featuring our study on endothelial RTK/integrin crosstalk—where ANGPT2 simultaneously engages two receptors! Big thanks to @johannaivaska@bsky.social and all co-authors and funders. @HelsinkiUniMed @helsinkiuni doi.org/10.1172/JCI1... #vascularbiology
JCI - Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling
doi.org
Journal of Clinical Investigation@jci.org · 4mo agoInactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling: doi.org/10.1172/JCI1...
Hot off the press! We demonstrate in @theaacr.bsky.social that the αv integrin- and neuropilin-1 (NRP-1)-dual targeting iRGD peptide (in phase II clinical trials) reverses some of these tumor microenvironment features by inhibiting TGF-β activation in the tumor aacrjournals.org/cancerres/ar...
Congratulations to Tappara on the win once again! 🏆 We’re proud to see one of our researchers Raine Sihvonen celebrating with the team as Tappara’s doctor. Our researchers do many things, and supporting sports is one of them! #Tappara #Research #IceHockey #Orthopedics
With some big delays, but it's nice to see the fruitful collaboration with @terojarvinen.bsky.social and @carolinacabalin.bsky.social out in a nice package!
Tero Järvinen@terojarvinen.bsky.social · 6mo agoOur work is out @eurjimmunol.bsky.social Dynamic Thymic Stromal Lymphopoietin and Its Receptor Complex Expression on Skin Langerhans Cells in Skin Inflammation - González‐Rodríguez - 2026 - European Journal of Immunology - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/...
MedicalResearch.com now interview with Teppo Järvinen, Professor of Orthopaedics and Traumatology, University of Helsinki and HUS. You can find more information about the interview here: medicalresearch.com/nejm-arthros...
NEJM: Arthroscopic Partial Meniscectomy Provided No Benefit Over Placebo Surgery and May Worsen Longterm Outcomes
This study contributes to the concept of medical reversal, where widely used treatments are shown to be ineffective or harmful when tested rigorously.
medicalresearch.com
In the FIDELITY trial of arthroscopic partial meniscectomy for degenerative medial meniscal tear in adults, participant-reported and radiologic outcomes over 10 years of follow-up suggested no benefit and possible harm from the procedure. Full trial results: https://nej.md/48Pkwww #Orthopedics
Over the moon to see this work from my PhD finally published in Development! Using a combination of structural biology and genetics we identify an avidity-driven mechanism of BMP signal control in the extracellular space. (1/11)
Development@dev-journal.bsky.social · 5mo agoAn avidity-driven mechanism of extracellular BMP regulation by Twisted gastrulation Read this Research Article from our special issue #DevSIextracellular by @garethmoore.bsky.social, @hilaryashe.bsky.social & co from @mcf-uom.bsky.social. journals.biologists.com/dev/article/... #Drosophila
In 2002, I watched hundreds of surgeons jump out of their seats to blast a speaker. @nejm.org Arthroscopic Partial Meniscectomy for Degenerative Tear — 10-Year Outcomes | New England Journal of Medicine www.nejm.org/doi/full/10....
Arthroscopic Partial Meniscectomy for Degenerative Tear — 10-Year Outcomes | NEJM
In this trial of arthroscopic partial meniscectomy for degenerative medial meniscal tear in adults, participant-reported and radiologic outcomes over 10 years of follow-up suggested no benefit and ...
nejm.org
Hot off the press! ☝️ Arthroscopic Partial Meniscectomy for Degenerative Tear — 10-Year Outcomes | New England Journal of Medicine www.nejm.org/doi/full/10....
Arthroscopic Partial Meniscectomy for Degenerative Tear — 10-Year Outcomes | NEJM
In this trial of arthroscopic partial meniscectomy for degenerative medial meniscal tear in adults, participant-reported and radiologic outcomes over 10 years of follow-up suggested no benefit and ...
nejm.org
The FIDELITY 10-year results have been published in the New England Journal of Medicine. You can find the full article through the link in the comments. #FIDELITY #NEJM #MedicalResearch
A significant milestone for the field and a proud moment for everyone involved. ✨
FICEBO@ficebo.bsky.social · 5mo agoThe FIDELITY 10-year results have been published in the New England Journal of Medicine. You can find the full article through the link in the comments. #FIDELITY #NEJM #MedicalResearch
Dr. Tuomas Komulainen, M.D. wrapped up his PhD Thesis demonstrating that the recruitment of anti-inflammatory M2 macrophages are important for keloid resolution after corticosteroids therapy. A double-blinded, randomized, controlled trial. @thejidjournal.bsky.social www.jidonline.org/article/S002...
Anti-Inflammatory Macrophages Are Recruited to the Keloids that Obtain Response to Intralesional Injection Therapies: Before and After Treatment Biopsies from a Double-Blinded, Randomized, Controlled ...
We explored the predictive value of immune cell populations to intralesional injections using biopsies collected from the active border of keloids before and after injections in the double-blinded ran...
jidonline.org
